First Trust Advisors
MDGL icon

First Trust Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

First Trust Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Sell
19,826
-2,407
-11% -$1.23M 0.01% 1190
2026
Q1 		$11.6M Sell
22,233
-2,586
-10% -$1.24M 0.01% 1043
2025
Q4 		$14.5M Buy
24,819
+21,024
+554% +$10.7M 0.01% 967
2025
Q3 		$1.74M Buy
3,795
+2,049
+117% +$764K ﹤0.01% 1897
2025
Q2 		$528K Sell
1,746
-3,062
-64% -$912K ﹤0.01% 2250
2025
Q1 		$1.59M Buy
4,808
+794
+20% +$261K ﹤0.01% 1871
2024
Q4 		$1.24M Buy
4,014
+1,352
+51% +$380K ﹤0.01% 1990
2024
Q3 		$565K Buy
+2,662
New +$681K ﹤0.01% 2146
2021
Q1 		– Sell
-3,286
Closed -$365K – 2437
2020
Q4 		$365K Buy
3,286
+1,213
+59% +$148K ﹤0.01% 2185
2020
Q3 		$246K Buy
+2,073
New +$225K ﹤0.01% 2200
2018
Q4 		– Sell
-1,193
Closed -$255K – 2449
2018
Q3 		$255K Buy
+1,193
New +$299K ﹤0.01% 2340

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors's MDGL Position: Q2 2026 in Review

First Trust Advisors reduced its Madrigal Pharmaceuticals (MDGL) stake by 11% in Q2 2026, selling an estimated $1.23M and leaving 19,826 shares worth $10.6M. The position accounts for 0.01% of the portfolio, ranked #1190.

First Trust Advisors first reported a position in MDGL in Q3 2018 and has held it in 11 quarters since. The position peaked at $14.5M in Q4 2025. 415 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • First Trust Advisors held 19,826 shares of Madrigal Pharmaceuticals worth $10.6M as of Q2 2026.
  • First Trust Advisors sold 2,407 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $1.23M.
  • Madrigal Pharmaceuticals made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1190 holding.
  • First Trust Advisors first reported a position in Madrigal Pharmaceuticals in Q3 2018 and has held it in 11 quarters since.
  • First Trust Advisors's Madrigal Pharmaceuticals position peaked at $14.5M in Q4 2025.
  • 415 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.